arrow
Back
J

Joaquı́n Mateo

vall dhebron institute of oncology

60H-index
450Paper Count
2.4WCitation Count
Published Papers 132
Publication Date
Combination therapy overcomes secondary PARPi resistance in ATM-deficient prostate cancer
err2025-11-26
err0
errOAAI
errSara Arce-Gallego; Victor Esquefa; Heura Domenech; Andrei Salca; Daniel Aguilar; Teresa Casals; Gisela Mir; Sara Simonetti; Anna Oliveira; Lara de Llobet; Antje Neeb; Julian Brandariz; Nicolas Anselmino; Irene Casanova-Salas; Nicolas Herranz; Violeta Serra; Johann S. de Bono; Joaquin Mateo
errShare
errSave
Clinically feasible liver tumour cell size measurement through histology-informed in vivo diffusion MRI
err2025-11-20
err0
errOAAI
errFrancesco Grussu; Athanasios Grigoriou; Kinga Bernatowicz; Marco Palombo; Irene Casanova-Salas; Daniel Navarro-Garcia; Ignasi Barba; Sara Simonetti; Garazi Serna; Carlos Macarro; Anna Kira Voronova; Valezka Garay; Juan Francisco Corral; Marta Vidorreta; Pablo García-Polo García; Xavier Merino; Richard Mast; Núria Rosón; Manuel Escobar; Maria Vieito; Rodrigo Toledo; Paolo Nuciforo; Joaquin Mateo; Elena Garralda; Raquel Perez-Lopez
errShare
errSave
Genomic actionability and matched targeted therapy in a decade-long institutional precision medicine program for solid tumors
err2025-11-06
err0
errOAAI
errR. Dienstmann; A. Vivancos; P. Nuciforo; S. Aguilar; F. Ruiz-Pace; C. Viaplana; J. Gonzalez; B. Fite; A. Pedrola; E. Elez; C. Saura; E. Felip; T. Macarulla; J. Capdevila; L. Fariñas-Madrid; J. Carles; J. Mateo; E. Muñoz-Cosuelo; J. Balmaña; I. Braña; E. Garralda; J. Tabernero
errShare
errSave
Therapy-induced senescence in prostate cancer: Mechanisms, therapeutic strategies, and clinical implications
errGene
IF2.4
err2025-09-22
err0
PREAI
errLuisa Bacca; Julian Brandariz; Francesca Zacchi; Andrea Zivi; Joaquin Mateo; David P. Labbé
errShare
errSave
PKA-driven SPP1 activation as a novel mechanism connecting the bone microenvironment to prostate cancer progression
err2025-08-02
err0
errOAAI
errPablo Sanchis; Agustina Sabater; Julia Lechuga; Jimena Rada; Rocio Seniuk; Gaston Pascual; Mora Gatti; Juan Bizzotto; Peter D. A. Shepherd; Jun Yang; Javier Cotignola; Elba Vazquez; Joaquin Mateo; Pia Valacco; Estefania Labanca; Christopher Logothetis; Geraldine Gueron; Nicolas Anselmino
errShare
errSave
Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node Metastasis
err2025-07-12
err0
PREAI
errAmado J. Zurita; Rebecca S. Tidwell; Brian F. Chapin; Deborah R. Harris; Miao Zhang; Louis L. Pisters; Ana Aparicio; John C. Araujo; Sara Arce-Gallego; Keyi Zhu; Maria L. Lozano; Lance Pagliaro; Joaquin Mateo; Christopher Logothetis; Patricia Troncoso; John W. Davis
errShare
errSave
Circulating tumor DNA clearance as a predictive biomarker of pathologic complete response in patients with solid tumors treated with neoadjuvant immune checkpoint inhibitors: a systematic review and meta-analysis
err2025-04-03
err0
PREAI
errC. Valenza; E.F. Saldanha; Y. Gong; P. De Placido; D. Gritsch; H. Ortiz; D. Trapani; F. Conforti; C. Cremolini; S. Peters; J. Mateo; V. Subbiah; H.A. Parsons; A.H. Partridge; G. Curigliano
errShare
errSave
A CT-based deep learning-driven tool for automatic liver tumor detection and delineation in patients with cancer
err2025-04-01
err0
errOAAI
errBalaguer-Montero, Maria; Morales, Adria Marcos; Ligero, Marta; Zatse, Christina; Leiva, David; Atlagich, Luz M.; Staikoglou, Nikolaos; Viaplana, Cristina; Monreal, Camilo; Mateo, Joaquin; Hernando, Jorge; Garcia-Alvarez, Alejandro; Salva, Francesc; Capdevila, Jaume; Elez, Elena; Dienstmann, Rodrigo; Garralda, Elena; Perez-Lopez, Raquel
errShare
errSave
Impact of gold nanoparticle size and coating on radiosensitization and generation of reactive oxygen species in cancer therapy
err2025-01-01
err0
errOAAI
errLoscertales, E.; Lopez-Mendez, R.; Mateo, J.; Fraile, L. M.; Udias, J. M.; Espinosa, A.; Espana, S.
errShare
errSave
Recent and Future Developments in the Use of Poly (ADP-ribose) Polymerase Inhibitors for Prostate Cancer
err2024-12-01
err0
PREAI
errFrancesca Zacchi; Wassim Abida; Emmanuel S. Antonarakis; Alan H. Bryce; Elena Castro; Heather H. Cheng; Shahneen Shandhu; Joaquin Mateo
errShare
errSave
ESMO Recommendations on clinical reporting of genomic test results for solid cancers
err2024-11-01
err0
errOAAI
errvan de Haar, J.; Roepman, P.; Andre, F.; Balmana, J.; Castro, E.; Chakravarty, D.; Curigliano, G.; Czarnecka, A. M.; Dienstmann, R.; Horak, P.; Marchio, C.; Italiano, A.; Monkhorst, K.; Pritchard, C. C.; Reardon, B.; Russnes, H. E. G.; Sirohi, B.; Sosinsky, A.; Spanic, T.; Turnbull, C.; Van Allen, E.; Westphalen, C. B.; Tamborero, D.; Mateo, J.
errShare
errSave
The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development
err2024-11-01
err2
errOAAI
errWestphalen, C. B.; Martins-Branco, D.; Beal, J. R.; Cardone, C.; Coleman, N.; Schram, A. M.; Halabi, S.; Michiels, S.; Yap, C.; Andre, F.; Bibeau, F.; Curigliano, G.; Garralda, E.; Kummar, S.; Kurzrock, R.; Limaye, S.; Loges, S.; Marabelle, A.; Marchio, C.; Mateo, J.; Rodon, J.; Spanic, T.; Pentheroudakis, G.; Subbiah, V.
errShare
errSave
Cyclophilin D plays a critical role in the survival of senescent cells
err2024-10-24
err0
PREAI
errProtasoni, Margherita; Lopez-Polo, Vanessa; Attolini, Camille Stephan-Otto; Brandariz, Julian; Herranz, Nicolas; Mateo, Joaquin; Ruiz, Sergio; Fernandez-Capetillo, Oscar; Kovatcheva, Marta; Serrano, Manuel
errShare
errSave
First results from ZZFIRST: A randomized phase II trial of enzalutamide (EZ) with or without talazoparib (TALA) in metastatic hormone-naive prostate cancer (mHNPC)
err2024-09-01
err0
PREAI
errMateo, J.; Castro, E.; Rodriguez-Vida, A.; Mellado Gonzalez, B.; Castellano Gauna, D. E.; Climent Duran, M. A.; Borque Fernando, A.; Saez, M. I.; Herrera Imbroda, B.; Font Pous, A.; Lorente, D.; Planas Morin, J.; Vivancos, A.; Cardona, J.; Guerrero, A.; Perez-Escuredo, J.; Saavedra, J. Zurita; Galceran, J. C.
errShare
errSave
Metastatic hormone-naïve prostate cancer: a distinct biological entity
err2024-09-01
err0
errOAAI
errCorres-Mendizabal, Jon; Zacchi, Francesca; Martin-Martin, Natalia; Mateo, Joaquin; Carracedo, Arkaitz
errShare
errSave
177Lu-PSMA-617 for metastatic prostate cancer: aiming for the right spot
errLANCET
IF88.5
err2024-09-01
err0
PREAI
errMateo, Joaquin; Zurita, Amado J.
errShare
errSave
Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial
err2024-09-01
err6
PREAI
errGarcia-Ruiz, Alonso; Macarro, Carlos; Zacchi, Francesca; Morales-Barrera, Rafael; Grussu, Francesco; Casanova-Salas, Irene; Sanguedolce, Francesco; Gonzalez, Macarena; Cresta-Morgado, Pablo; de Albert, Matias; Garcia-Bennett, Josep; Marmolejo, David; Planas, Jacques; Roche, Sarai; Mast, Richard; Zatse, Christina; Piulats, Josep M.; Herrera-Imbroda, Bernardo; Regis, Lucas; Agundez, Laura; Olmos, David; Calvo, Nahum; Escobar, Manuel; Carles, Joan; Mateo, Joaquin; Perez-Lopez, Raquel
errShare
errSave
The TALAPRO-3 study design: a plain language summary
err2024-07-24
err0
errOAAI
errAgarwal, Neeraj; Saad, Fred; Azad, Arun A.; Mateo, Joaquin; Matsubara, Nobuaki; Shore, Neal D.; Chakrabarti, Jayeta; Chen, Hsiang-Chun; Lanzalone, Silvana; Niyazov, Alexander; Fizazi, Karim
errShare
errSave
Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group
err2024-07-01
err21
errOAAI
errMosele, M. F.; Westphalen, C. B.; Stenzinger, A.; Barlesi, F.; Bayle, A.; Bieche, I.; Bonastre, J.; Castro, E.; Dienstmann, R.; Kramer, A.; Czarnecka, A. M.; Meric-Bernstam, F.; Michiels, S.; Miller, R.; Normanno, N.; Reis-Filho, J.; Remon, J.; Robson, M.; Rouleau, E.; Scarpa, A.; Serrano, C.; Mateo, J.; Andre, F.
errShare
errSave